Clinical Research on Orphan Drugs

The Orphan Drug clinical exploration program provides orphan status to medicines and biologics which are defined as those intended for the treatment, forestalment or opinion of a rare complaint or situation, which is one that disturb lower than persons. We can see momentous progress in the development of treatments for rare conditions, also known as orphan medicines. Especially the agency authorized 32 new medicines and biologics with title named as orphan medicines

    Related Conference of Clinical Research on Orphan Drugs

    July 15-16, 2024

    38th International Conference on Immunology

    Toronto, Canada

    Clinical Research on Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in